Kentucky sets launch date for medical marijuana sales

The state's oversight agency is still finalizing many rules about the market.

The medical marijuana trade in Kentucky will officially launch on New Year’s Day of 2025.

But before then, there’s still a lot that the state needs to sort out, the Louisville Courier Journal reported.

Although an initial set of industry regulations was released in January, the Cabinet for Health and Family Services must still put finishing touches on industry regulations, which are still in the works and may not be done for several more months, an agency spokesman told the Courier Journal.

“In the coming weeks and months, the Cabinet will promulgate additional regulations on how patients and caregivers can become cardholders and how individuals and businesses can apply for a medical cannabis business license,” the spokesperson said.

For instance, it’s not yet clear if the state will cap the number of MMJ businesses allowed to operate. The law which created the program doesn’t have a limit on dispensaries, growers, or other business types.

The state legislature also needs to approve the rules, and a public comment period is on the calendar for March 25.

Of the rules issued to date, those of primary importance include:

  • All medical marijuana cultivation must be done indoors.
  • Packaging and labeling standards will be strict, in part to discern MMJ from hemp-based goods.
  • Only those 21 and over can buy MMJ products without supervision by a parent, including vaping devices; parents will be allowed to purchase MMJ on behalf of their children.
  • Dispensaries will be barred from selling smoking accessories, such as rolling papers, lighters, or anything else that facilitates smoking cannabis.
  • Dispensaries will be allowed to sell raw marijuana flower, but the law requires it be only used to make edibles or tea at home, and smoking MMJ is technically prohibited.

Separately, an effort is underway at the Kentucky Legislature to broaden the number of qualifying medical conditions that will make consumers eligible to legally purchase medical cannabis, a move that already has the support of Democratic Gov. Andy Beshear.

Senate Bill 337, authored by Sen. Stephen West, would increase the number of medical ailments to 21 from just six in the current law, Louisville Public Media reported. Currently, only those with cancer, severe pain, epilepsy or other seizure disorders, multiple sclerosis or muscle spasms, chronic nausea or post-traumatic stress disorder are eligible for the MMJ program.

West wants to add to that list:

  • HIV and AIDS
  • ALS/Lou Gehrig’s disease
  • Arthritis
  • Cachexia or wasting syndrome
  • Fibromyalgia
  • Glaucoma
  • Hepatitis C
  • Huntington’s disease
  • Irritable bowel syndrome, including Crohn’s disease and ulcerative colitis
  • Muscular dystrophy
  • Neuropathies
  • Parkinson’s disease
  • Sickle cell disease
  • Any terminal illness

If West’s new bill is successful, the number of Kentucky residents eligible to purchase MMJ would be roughly 437,000, Beshear estimated at a press conference in January.

Avatar photo

John Schroyer

John Schroyer has been a reporter since 2006, initially with a focus on politics, and covered the 2012 Colorado campaign to legalize marijuana. He has written about the cannabis industry specifically since 2014, after being on hand for the first-ever legal cannabis sales on New Year’s Day that year in Denver. John has covered subsequent marijuana market launches in California and Illinois, has written about every aspect of the marijuana trade, and was part of the team that built the cannabis industry’s first-ever trade show, MJBizCon. He joined Green Market Report in 2022.


2 comments

  • Katherine Bhana

    March 5, 2024 at 7:41 am

    ALS is a cruel disease. My mum is 83 and had great difficulty speaking and swallowing much of anything. Food was getting trapped in her throat and blocking her air way was happening more often. she battled for each breath. The riluzole did very little to help her. The medical team did even less. Her decline was rapid and devastating. The psychological support from the medical centre was non-existent and if it were not for the sensitive care and attention of our primary physician, there she would have died. There has been little if any progress in finding a cure or reliable treatment. Acupuncture eased her anxiety a bit. this year our primary physician started her on Natural Herbs Centre ALS/MND Ayurvedic treatment, 6 months into treatment she improved dramatically. It has been a complete turnaround with her speech, she no longer needs the feeding tube to feed, the treatment is a miracle. She recovered significantly!

    Reply

  • Katherine Bhana

    March 11, 2024 at 11:54 pm

    ALS is a cruel disease. My mum is 83 and had great difficulty speaking and swallowing much of anything. Food was getting trapped in her throat and blocking her air way was happening more often. she battled for each breath. The riluzole did very little to help her. The medical team did even less. Her decline was rapid and devastating. The psychological support from the medical centre was non-existent and if it were not for the sensitive care and attention of our primary physician, there she would have died. There has been little if any progress in finding a cure or reliable treatment. Acupuncture eased her anxiety a bit. this year our primary physician started her on Natural Herbs Centre ALS/MND Ayurvedic treatment, 6 months into treatment she improved dramatically. It has been a complete turnaround with her speech, she no longer needs the feeding tube to feed, the treatment is a miracle. She recovered significantly!

    Reply

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE